Perspectives in Clinical Nephrology

Kidney International (1995) 47, 1491–1499; doi:10.1038/ki.1995.211

Chronic renal transplant loss

Leendert C Paul

Toronto, Ontario, Canada

Correspondence: Dr L C Paul, Division of Nephrology, University of Toronto at St. Michael's Hospital, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada.

Received 11 July 1994; Revised 9 October 1994; Accepted 10 October 1994.

Top

References

  1. Schweitzer EJ, Matas AJ, Gillingham KJ, Payne WD, Gores PF, Dunn DL, Sutherland DER, Najarian JS: Causes of renal allograft loss. Ann Surg 214:679–688, 1991 | PubMed | ISI | ChemPort |
  2. Cook DJ: Long term survival of kidney allografts, in Clinical Transplants 1987, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1987, pp 277–285
  3. Almond PS, Matas A, Gillingham KJ, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS: Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752–757, 1993 | PubMed | ISI | ChemPort |
  4. Yilmaz S, Häyry P: The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 56:1153–1156, 1993 | PubMed | ISI | ChemPort |
  5. Cheigh JS, Stenzel KH, Susin M, Rubin AL, Riggio RR, Whitsell JC: Kidney transplant nephrotic syndrome. Am J Med 57:730–740, 1974
  6. Paul LC, Häyri P, Foegh M, Dennis MJ, Mihatsch M, Larsson E, Fellström B: Diagnostic criteria for chronic rejection/accelerated graft atherosclerosis in heart and kidney transplants: Proposal from the Fourth Alexis Carrel Conference on Chronic Rejection and Accelerated Arteriosclerosis in Transplanted Organs. Transplant Proc 25:2020–2021, 1993
  7. Kirkman RL, Strom TB, Weir MR, Tilney NL: Late mortality and morbidity in recipients of long-term allografts. Transplantation 34:347–351, 1982 | PubMed | ISI | ChemPort |
  8. Paul LC, Fellström B: Chronic vascular rejection of the heart and the kidney—Have rational treatment options emerged? Transplantation 53:1169–1179, 1992 | PubMed | ISI | ChemPort |
  9. Rao KV, Kasiske BL, Bloom PM: Acute graft rejection in the late survivors of renal transplantation. Clinical and histological observations in the second decade. Transplantation 47:290–292, 1989
  10. Foster MC, Dennis MJS: Chronic renal graft rejection, in Organ Transplantation: Long Term Results, edited by Paul LC, Solez K, New York, Marcel Dekker Inc, 1992, pp 153–172
  11. Mason DW, Morris PJ: Effector mechanisms in allograft rejection. Ann Rev Immunol 4:119–145, 1986
  12. Nadasdy T, Krenacs T, Kalmar KN, Csajbok E, Bouda K, Ormos J: Importance of plasma cells in the infiltrate of renal allografts. An immunohistochemical study. Pathol Res Pract 187:178–183, 1991 | PubMed | ISI | ChemPort |
  13. Stein-Oakley AN, Jablonski P, Tzanidis A, Baxter K, Howden BO, Marshall VC, Thomson NM: Development of chronic injury and nature of interstitial infiltrate in a model of chronic renal allograft rejection. Transplantation 56:1299–1305, 1993
  14. Paul LC, Grothman GT, Benediktsson H, Davidoff A, Rozing J: Macrophage subpopulations in normal and transplanted heart and kidney tissues in the rat. Transplantation 53:157–162, 1992 | PubMed | ISI | ChemPort |
  15. Gouldesbrough DR, Axelsen RA: Arterial endothelialitis in chronic renal allograft rejection: A histopathological and immunocytochemical study. Nephrol Dial Transplant 9:35–40, 1994 | PubMed | ISI | ChemPort |
  16. Monga G, Mazzucco G, Messina M, Motta M, Quaranta S, Novara R: Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens. Mod Pathol 5:125–130, 1992 | PubMed | ISI | ChemPort |
  17. Merrill JP: Glomerulonephritis in renal transplants. Transplant Proc 1:994–1004, 1969
  18. Barrientos A, Portolés J, Herrero JA, Torralbo A, Prats D, Gutierrez-Millet V, Blanco J: Glomerular hyperfiltration as a nonimmunologic mechanism of progression of chronic renal rejection. Transplantation 57:753–756, 1994 | PubMed | ISI | ChemPort |
  19. Ettenger RB, Heuser ET, Malekzadeh MH, Pennisi AJ, Uittenbogaart CM, Fine RN: Focal glomerulosclerosis in renal allografts. Association with the nephrotic syndrome and chronic rejection. Am J Dis Child 131:1347–1352, 1977
  20. Cheigh JS, Mouradian J, Soliman M, Tapai L, Riggio RR, Stenzel KH, Rubin AL: Focal segmental glomerulosclerosis in renal transplants. Am J Kidney Dis 2:449–455, 1983 | PubMed | ISI | ChemPort |
  21. Hamburger J, Crosnier J, Dormont JA: Observations in patients with a well tolerated homotransplanted kidney. Ann NY Acad Sci 120:558–577, 1964 | PubMed | ChemPort |
  22. Rossmann P, Jirka J, Malek P, Hejnal J: Glomerulopathies in human renal allografts. Beitr Pathol Bd 155:18–35, 1975
  23. Olsen S, Bohman S-O, Petersen VP: Ultrastructure of the glomerular basement membrane in long term renal allografts with transplant glomerular disease. Lab Invest 30:176–189, 1974
  24. Petersen VP, Olsen TS, Kissmeyer-Nielsen F, Bohman SD, Hansen HE, Hansen ES, Skov PE, Solling K: Late failure of human renal transplants. An analysis of transplant disease and graft failure among 125 recipients surviving for one to eight years. Medicine 54:45–71, 1975
  25. Busch GJ, Galvanek EG, Reynolds ES: Human renal allografts. Analysis of lesions in long-term survivors. Human Pathol 12:253–298, 1971
  26. Zollinger HU, Moppert J, Thiel G, Rohr HP: Morphology and pathogenesis of glomerulopathy in cadaver kidney allografts treated with antilymphocyte globulin. Curr Top Pathol 57:1–48, 1973
  27. Cameron JS, Turner DR: Recurrent glomerulonephritis in allografted kidneys. Clin Nephrol 7:47–54, 1977
  28. Habib R, Antigua C, Hinglais N, Gagnadoux MF, Broyer M: Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis 10:198–207, 1987 | PubMed | ISI | ChemPort |
  29. Olsen TS: Pathology of allograft rejection, in Kidney Transplant Rejection, (2nd ed) edited by Burdick JF, Racusen LC, Solez K, New York, Marcel Dekker Inc, 1992, pp 333–357
  30. Habib R, Zurowska A, Hinglais N, Gubler MC, Antignac C, Niaudet P, Broyer M, Gagnadoux MF: A specific glomerular lesion of the graft: Allograft glomerulopathy. Kidney Int 44(Suppl 42):S104–S111, 1993 | ISI |
  31. Habib R, Broyer M: Clinical significance of allograft glomerulopathy. Kidney Int 44 (Suppl 43):S95–S98, 1993 | ISI |
  32. Isoniemi HM, Krogerus L, Von Willebrand E, Taskinen E, Ahonen J, Häyry P: Histopathological findings in well-functioning, long-term renal allografts. Kidney Int 41:155–160, 1992 | PubMed | ISI | ChemPort |
  33. Rush DN, Henry SF, Jeffery JR, Schroeder TJ, Cough J: Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 57:208–211, 1994 | PubMed | ISI | ChemPort |
  34. Naimark DMJ, Cole E: Determinants of long-term renal allograft survival. Transplant Rev 8:93–113, 1994
  35. Terasaki PI, Cecka JM, Gjertson DW, Cho Y, Takemoto S, Cohn M: A ten year prediction for kidney transplant survival, in Clinical Transplants, 1992, edited by Terasaki PI, Cecka JM, Los Angeles, UCLA Tissue Typing Laboratory, 1993, pp 501–512
  36. Thorogood J, Van Houwelingen HC, Van Rood JJ, Zantvoort FA, Schreuder GMT, Persijn GG: Long-term results of kidney transplantation in Eurotransplant, in Organ Transplantation: Long Term Results, edited by Paul LC, Solez K, New York, Marcel Dekker Inc, 1992, pp 33–56
  37. Opelz G, for the Collaborative Transplant Study: Collaborative transplant study—10-year report. Transplant Proc 24:2342–2355, 1992 | PubMed | ChemPort |
  38. Cecka JM, Terasaki PJ: The UNOS Scientific renal transplant registry, in Clinical Transplants, 1992, edited by Terasaki PI, Cecka JM, Los Angeles, UCLA Tissue Typing Laboratory, 1993, pp 1–16
  39. Cecka JM: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin Transplant 8:324–327, 1994 | PubMed | ISI | ChemPort |
  40. Cecka JM, Terasaki PI: Early rejection episodes, in Clinical Transplants 1989, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, 1989, pp 425–434
  41. Matas AJ, Gillingham KJ, Payne WD, Najarian JS: The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 57:857–859, 1994 | PubMed | ISI | ChemPort |
  42. Isoniemi H, Nurminen M, Tikkanen MJ, Von Willebrand E, Krogerus L, Ahonen J, Eklund B, Höckerstedt K, Salmela K, Häyry P: Risk factors predicting chronic rejection of renal allografts. Transplantation 57:68–72, 1994 | PubMed | ISI | ChemPort |
  43. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC: Long-term efficacy and safety of cyclosporin in renal-transplant patients. N Engl J Med 331:358–363, 1994 | Article | PubMed | ISI |
  44. Bittar AE, Keitel E, Garcia CD, Bruno RM, Silviera AE, Messias A, Garcia VD: Patient non-compliance as a cause of late kidney graft failure. Transplant Proc 24:2720–2721, 1992 | PubMed | ISI | ChemPort |
  45. Dimény E, Wahlberg J, Lithell H, Fellström B: Hyperlipidaemia in renal transplantation. Risk factor for long-term graft outcome, in Metabolic Factors and Outcome of Organ Transplantation, edited by Dimény E, Academic thesis, Uppsala University, Sweden, 1994
  46. Cho YW, Terasaki PI, Graver B: Fifteen year kidney graft survival, in Clinical Transplants 1989, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, pp 325–334
  47. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA: The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 38:643–648, 1984 | PubMed | ISI | ChemPort |
  48. Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith ER, Tasi SY, Bear RA, Cole EH, Fenton SS, Cattran DC: Early function as the principal correlate of graft survival. Transplantation 46:223–228, 1988 | PubMed | ISI | ChemPort |
  49. Brenner BM, Cohen RA, Milford EL: In renal transplantation, one size may not fit all. JASN 3:162–169, 1992
  50. Yuge J, Cecka JM: Sex and age effects in renal transplantation, in Clinical Transplants 1991, edited by Terasaki PI, Los Angeles, UCLA Tissue Typing Laboratory, pp 257–267
  51. Terasaki PI, Koyama H, Cecka JM, Gjertson DW: The hyperfiltration hypothesis in human renal transplantation. Transplantation 57:1450–1454, 1994 | PubMed | ISI | ChemPort |
  52. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE: Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566, 1989 | Article | PubMed | ISI | ChemPort |
  53. Richardson WP, Colvin RB, Cheeseman SK, Tolkoff-Rubin NE, Herrin JT, Cosimi AB, Collins AB, Hirsch MS, McCluskey RT, Russell PS, Rubin RH: Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med 305:57–63, 1981 | PubMed | ISI | ChemPort |
  54. Tuazon TV, Schneeberger EE, Bahn AK, McCluskey RT, Cosimi AB, Schooley RT, Rubin RH, Colvin RB: Mononuclear cells in acute allograft glomerulopathy. Am J Pathol 129:119–132, 1987 | PubMed | ISI | ChemPort |
  55. Herrera GA, Alexander RW, Cooley CF, Luke RG, Kelly DR, Curtis JJ, Gockerman JP: Cytomegalovirus glomerulopathy: A controversial lesion. Kidney Int 29:725–733, 1986
  56. Mosmann TR, Cherwinski H, Bond MW, Giedllin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348–2357, 1986 | PubMed | ISI | ChemPort |
  57. Street NE, Mosmann TR: Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J 5:171–177, 1991 | PubMed | ISI | ChemPort |
  58. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241–251, 1994 | Article | PubMed | ISI | ChemPort |
  59. Seder RA, Paul WE, Davis MM, Fazekas de St Groth B: The presence of interleukin-4 during in vitro priming determines the lymphokine-producing potential of CD4+ from T cell receptor transgenic mice. J Exp Med 176:1091–1098, 1992 | Article | PubMed | ISI | ChemPort |
  60. Romagnani S: Human TH1 and TH2 subsets: Doubt no more. Immunol Today 12:256–257, 1991 | Article | PubMed | ISI | ChemPort |
  61. Kemeny DM, Noble A, Holmes BJ, Diaz-Sanchez D: Immune regulation: A new role for the CD8+ cell. Immunol Today 15:107–110, 1994 | Article | PubMed | ISI | ChemPort |
  62. Broski AP, Halloran PF: Tissue distribution of IL-10 mRNA in nomal mice: Expression is T and B cell independent and increased by irradiation. Transplantation (in press)
  63. Ong ACM, Fine LG: Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am J Kidney Dis 23:205–209, 1994 | PubMed | ISI | ChemPort |
  64. Rook GAW, Hernandez-Pando R, Lightman SL: Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 15:301–303, 1994 | Article | PubMed | ChemPort |
  65. Lowry RP, Takeuchi T, Cremisi H, Konieczny B, Someren A: Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously. Transplant Proc 25:2103–2105, 1993 | PubMed | ISI | ChemPort |
  66. Land W, Schneeberger H, Schleibner S, Illner WD, Abendroth D, Hillebrand G, Gokel JM, Albert E: Long-term results in cadaveric renal transplantation under cyclosporine therapy. Transplant Proc 23:1244–1246, 1991
  67. Tesi RJ, Henry ML, Elkhammas EA, Ferguson RM: Predictors of long-term primary cadaveric renal transplant survival. Clin Transplant 7:345–352, 1993 | ISI |
  68. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, Croker BP, Droz D, Dunnill MS, Halloran PF, Häyry P, Jennette JC, Keown PA, Marcussen N, Mihatsch MJ, Morozami K, Myers BD, Nast CC, Olsen S, Racusen LC, Ramos EL, Rosen S, Sachs DH, Salomon DR, Sanfilippo F, Verani R, Von Willebrand E, Yamaguchi Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411–422, 1993 | Article | PubMed | ISI | ChemPort |
  69. Hutchinson IV: Immunological mechanisms of long-term graft acceptance, in Organ Transplantation. Long-Term Results, edited by Paul LC, Solez K, New York, Marcel Dekker Inc, 1992, pp 1–31
  70. Paul LC, Baldwin WM, Van Es LA: Vascular endothelial alloantigens in renal transplantation. Transplantation 40:117–123, 1985
  71. Colson YL, Markus BH, Zeevi A, Duquesnoy RJ: Interactions between endothelial cells and alloreactive T cells involved in graft immunity. Transplant Proc 20:273–275, 1988
  72. Miltenburg AMM, Meijer-Paape ME, Daha MR, Paul LC: Endothelial cell lysis induced by lymphokine activated human peripheral blood mononuclear cells. Eur J Immunol 17:1383–1386, 1987
  73. Bender JR, Pardi R, Engleman E: T-cell receptor-negative natural killer cells display antigen-specific cytotoxicity for microvascular endothelial cells. Proc Natl Acad Sci USA 87:6949–6953, 1990
  74. Paul LC, Benediktsson H, Davidoff A, Issekutz TB: Effect of LFA-1 and VLA-4 antibody treatment on rat vascularized cardiac allograft rejection. Transplantation 55:1196–1199, 1993
  75. Hammond EH, Yowell RL, Price GD, Menlove RL, Olsen SL, O'Connell JB, Bristow MR, Doty DB, Millar RC, Karwande SV, Jones KW, Gay WA Jr, Renlund DG: Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 11:S111–S119, 1992
  76. Halloran PF, Schlaut J, Solez K, Srinivasa NS: The significance of the anti-class I response. II Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 53:550–555, 1992 | PubMed | ISI | ChemPort |
  77. Jeannet M, Pinn VW, Flax MH, Russell HS: Humoral antibodies in renal allotransplantation in man. N Engl J Med 282:111–117, 1970 | PubMed | ISI | ChemPort |
  78. Duijvestijn AM, Van Breda Vriesman PJC: Chronic renal allograft rejection. Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Transplantation 52:195–202, 1991
  79. De Heer E, Davidoff A, Van der Wal A, Van Geest M, Paul LC: Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest 70:494–502, 1994 | PubMed | ChemPort |
  80. Li B, Sehajpal PK, Khanna A, Vlassara H, Cerami A, Stenzel KH, Suthanthiran M: Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: Demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction. J Exp Med 174:1259–1262, 1991 | Article | PubMed | ISI | ChemPort |
  81. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA: Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int 40:1020–1031, 1991 | PubMed | ISI | ChemPort |
  82. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-beta1 underlies development of progressive kidney fibrosis. Kidney Int 45:916–927, 1994 | Article | PubMed | ISI | ChemPort |
  83. Woolley AC, Rosenberg ME, Burke BA, Nath KA: De novo focal glomerulosclerosis after kidney transplantation. Am J Med 84:310–315, 1988 | PubMed |
  84. Rao KV, Kasiske BL, Odlund MD, Ney AL, Andersen RC: Influence of cadaver donor age on post-transplant renal function and graft outcome. Transplantation 49:91–95, 1990
  85. Roth D, Burke G, Nery J, Esquenazi V, Miller J: Nephron dosing in renal transplantation: how much kidney is sufficient? (abstract) 13th Annual Meeting, American Society of Transplant Physicians, Chicago, 1994, p 50
  86. Hostetter TH, Olson JL, Rennke HG, Venkatachalan MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85–F93, 1981 | PubMed | ISI | ChemPort |
  87. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38:384–394, 1990 | Article | PubMed | ISI | ChemPort |
  88. Yoshida Y, Fogo A, Ichikawa I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654–664, 1989 | PubMed | ISI | ChemPort |
  89. Nath KA, Hostetter MK, Hostetter TH: Pathophysiology of chronic tubulointestitial disease in rats: Interactions of dietary acid load, ammonia and complement component C3. J Clin Invest 76:667–675, 1985 | PubMed | ISI | ChemPort |
  90. Alfrey AC: Role of iron and oxygen radicals in the progression of chronic renal failure. Am J Kidney Dis 23:183–187, 1994 | PubMed | ISI | ChemPort |
  91. Keane WF, Kasiske BL, O'Donnell MP: Lipids and progressive glomerulosclerosis. Am J Nephrol 8:261–271, 1988 | PubMed | ISI | ChemPort |
  92. Shimura T, Morrison AB: A progressive glomerulosclerosis occurring in partial five-sixth nephrectomized rats. Am J Pathol 79:95–106, 1975
  93. Anderson S, Rennke HG, Brenner BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993–2000, 1986 | PubMed | ISI | ChemPort |
  94. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307:652–659, 1982 | PubMed | ISI | ChemPort |
  95. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 325:1058–1062, 1991 | PubMed | ISI | ChemPort |
  96. Modena FM, Hostetter TH, Salahudeen AK, Najarian JS, Matas AJ, Rosenberg ME: Progression of kidney disease in chronic renal transplant rejection. Transplantation 52:239–244, 1991 | PubMed | ISI | ChemPort |
  97. Brazy PC, Pirsch JD, Belzer FO: Factors affecting renal allograft function in long-term recipients. Am J Kidney Dis 19:558–566, 1992 | PubMed | ISI | ChemPort |
  98. Cheigh JS, Haschemeyer RH, Wang JCL, Riggio RR, Tapia L, Stenzel KH, Rubin AL: Hypertension in kidney transplant recipients. Effect on long-term renal allograft survival. Am J Hypertens 2:341–348, 1989 | PubMed | ISI | ChemPort |
  99. Salahudeen AK, Hostetter TH, Raatz SK, Rosenberg ME: Effects of dietary protein in patients with chronic renal transplant rejection. Kidney Int 41:183–190, 1992 | PubMed | ISI | ChemPort |
  100. Feehally J, Bennett SE, Harris KPG, Wall J: Is chronic renal transplant rejection a non-immunological phenomenon? Lancet 2:486–488, 1986 | PubMed | ISI | ChemPort |
  101. Kootte AMM, 't Hart-Eerdmans M, Paul LC: Dietary protein manipulation or cyclosporine therapy in chronic renal allograft rejection. Clin Transplant 2:152–159, 1988
  102. Kingma I, Chea R, Davidoff A, Benediktsson H, Paul LC: Glomerular capillary pressures in long-surviving rat renal allografts. Transplantation 56:53–60, 1993 | PubMed | ISI | ChemPort |
  103. Junaid A, Kren SM, Rosenberg ME, Nath K, Hostetter TH: Physiological and structural responses to chronic experimental allograft injury. Am J Physiol 267:F1102–F1107, 1994 | PubMed | ISI | ChemPort |
  104. Paul LC: Functional and histological characteristics of chronic renal allograft rejection. Clin Transplant 8:319–323, 1994
  105. Hostetter TH: Chronic transplant rejection. Kidney Int 46:266–279, 1994 | Article | PubMed | ISI | ChemPort |
  106. Fellström B, Dimény E, Larsson E, Claesson K, Tufveson G: Rapidly proliferating arteriopathy in cyclosporin-induced permanently surviving rat cardiac allografts simulating chronic vascular rejection. Clin Exp Immunol 80:288–292, 1990
  107. Knight RJ, Kerman RH, Welsh M, Golden D, Schoenberg L, Van Buren CT, Lewis RM, Kahan BD: Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy. Transplantation 51:355–359, 1991
  108. Dimény E, Fellstöm B, Larsson E, Tufveson G, Lithell H: Chronic vascular rejection and hyperlipoproteinemia in renal transplant patients. Clin Transplant 7:482–490, 1993 | ISI |
  109. Eich D, Thompson JA, Ko DJ, Hastillo A, Lower R, Katz S, Katz M, Hess MJ: Hypercholesterolemia in long-term survivors of heart transplantation: An early marker of accelerated coronary artery disease. J Heart Lung Transplant 10:45–49, 1991
  110. Vollmer E, Bosse A, Bogeholz J, Roessner A, Blasius S, Fahrenkamp A, Bocker W: Apolipoproteins and immunohistological differentiation of cells in the arterial wall of kidneys in transplant arteriopathy. Morphological parallels with atherosclerosis. Pathol Res Pract 187:957–962, 1991 | PubMed | ISI | ChemPort |
  111. Yilmaz S, Paavonen T, Häyri P: Chronic rejection of rat renal allografts. II The impact of prolonged ischemia time on transplant histology. Transplantation 53:823–827, 1992 | PubMed | ISI | ChemPort |
  112. Coletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936–1943, 1990
  113. Goes N, Ramassar V, Urmson J, Halloran PF: Cytokine and growth factor changes after ischemic injury to the kidney. Abstr Am Soc Transplant Phys, 1994, Chicago
  114. Klausner JM, Paterson IS, Goldman G, Kobzik L, Rodzen C, Lawrence R, Valeri CR, Sherpo D, Hechtman HB: Post-ischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 256:F794–F802, 1989 | PubMed | ISI | ChemPort |
  115. Shoskes DA, Parfrey NA, Halloran PF: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 49:201–207, 1990 | PubMed | ISI | ChemPort |
  116. Springer T: Adhesion receptors of the immune system. Nature 346:425–434, 1990 | Article | PubMed | ISI | ChemPort |
  117. Kelly KJ, Williams WW, Colvin BB, Bonventre JV: Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA 91:812–816, 1994 | Article | PubMed | ChemPort |
  118. Sporn MB, Roberts AB: Peptide growth factors are multifunctional. Nature 332:217–219, 1988 | Article | PubMed | ISI | ChemPort |
  119. Dallman MJ: The cytokine network and regulation of the immune response to organ transplants. Transplant Rev 6:209–222, 1992
  120. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int 45 (Suppl 45):S11–S16, 1994 | ISI | ChemPort |
  121. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362:801–809, 1993 | Article | PubMed | ISI | ChemPort |
  122. Johnson RB: Monocytes and macrophages. N Engl J Med 318:747–752, 1988
  123. Perussia B: Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol 3:49–55, 1991 | PubMed |
  124. Yard BA, Daha MR, Kooymans-Couthino M, Bruijn JA, Paape ME, Schrama E, Van Es LA, Van der Woude FJ: IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells. Kidney Int 42:383–389, 1992 | Article | PubMed | ISI | ChemPort |
  125. Kuncio GS, Neilson EG, Haverty T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550–556, 1991 | PubMed | ISI | ChemPort |
  126. Kobayashi J, Zhu L, Rabinovitch M, Rabinovitch Z: Serum stimulation of elastase in vascular smooth muscle cells. (abstract) FASEB J (V7):A795, 1993
  127. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA: Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68:106–113, 1991 | PubMed | ChemPort |
  128. Prescott MF, McBride CK, Court M: Development of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol 135:835–846, 1989 | PubMed | ISI | ChemPort |
  129. Koo EWY, Gotlieb AI: Endothelial stimulation of intimai cell proliferation in a porcine aortic organ culture. Am J Pathol 134:497–503, 1989
  130. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917–924, 1988 | PubMed | ISI | ChemPort |
  131. Paul LC, Saito K, Ngo K, Davidoff A: Growth factors and receptor expression in rat renal allografts. (abstract) JASN 3:847, 1992
  132. Fellström B, Klareskog L, Heldin C-H, Larsson E, Rönnstrand L, Terracio L, Tufveson G, Wahlberg J, Rubin K: Platelet-derived growth factor receptors in the kidney-upregulated expression in inflammation. Kidney Int 36:1099–1102, 1989 | PubMed | ISI | ChemPort |
  133. Paul LC, Solez K: Chronic rejection in vascularized organ allografts, in Organ Transplantation: Long-Term Results, edited by Paul LC, Solez K, New York, Marcel Dekker Inc, 1992, pp 99–134
  134. Johnson R, Iida H, Yoshimura A, Floege J, Bowen-Pope DF: Platelet-derived growth factor: A potentially important cytokine in glomerular disease. Kidney Int 41:590–594, 1992 | PubMed | ISI | ChemPort |
  135. Waltenberger J, Miyazono K, Funa K, Wanders A, Fellström B, Heldin C-H: Transforming growth factor-beta and organ transplantation. Transplant Proc 25:2038–2040, 1993
  136. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alverez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor beta by human T lymphocytes; its potential role in the regulation of T cell growth. J Exp Med 163:1037–1050, 1986 | Article | PubMed | ISI | ChemPort |
  137. Wallick SC, Figari IS, Morris RE, Levinson AD, Palladino MA: Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells; comparison of active and latent TGF-beta-1. J Exp Med 172:1777–1784, 1990 | Article | PubMed | ISI | ChemPort |
  138. Verbanac KM, Carver FM, Haisch CE, Thomas JM: A role for transforming growth factor-beta in the veto mechanism in transplant tolerance. Transplantation 57:893–900, 1994 | PubMed | ISI | ChemPort |
  139. Xu G, Wang JC, Li B, Serur D, Mouradian KH, Stenzel KH, Suthanthiran M: Human renal graft rejection: Molecular characterization including quantification of intragraft gene expression. (abstract) Am Soc Transplant Phys, Houston, 1993, p 161
  140. Gould VE, Martinez-Lacabe V, Virtanen I, Sahlin KM, Schwartz MM: Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection. Lab Invest 67:71–79, 1992 | PubMed | ISI | ChemPort |
  141. Ruef C, Budde K, Lacy J, Northemann W, Bauman M, Sterzel RB, Coleman DL: Interleukin 6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249–257, 1990 | Article | PubMed | ISI | ChemPort |
  142. Ikeda M, Ikeda U, Ohara T, Kusano E, Kano S: Recombinant interleukin-6 inhibits the growth of rat mesangial cells in culture. Am J Pathol 141:327–334, 1992 | PubMed | ChemPort |
  143. Vandenbroecke C, Caillat-Zucman S, Legendre C, Noel LH, Kreis H, Woodrow D, Bach JF, Tovey MG: Differential in situ expression of cytokines in renal allograft rejection. Transplantation 51:602–609, 1991
  144. Hancock WH, Whitley WD, Tulius SC, Heemann VW, Wasowska B, Baldwin WM, Tilney NL: Cytokines, adhesion molecules and the pathogenesis of chronic renal allograft rejection. Transplantation 56:643–650, 1993 | PubMed | ISI | ChemPort |
  145. Clausell N, Molossi S, Sett S, Rabinovitch M: In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplantation inhibits acute coronary artery neointimal formation. Circulation 89:2768–2779, 1994 | PubMed | ISI | ChemPort |
  146. Russell PS, Chase CM, Winn HJ, Colvin RB: Coronary atherosclerosis in transplanted mouse hearts. III Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation 57:1367–1371, 1994 | PubMed | ISI | ChemPort |
  147. Fritze LM, Reilly CF, Rosenberg RD: An antiproliferative heparan sulfate species produced by post-confluent smooth muscle cells. J Cell Biol 100:1041–1049, 1985 | Article | PubMed | ChemPort |
  148. Aziz S, Tada Y, Gordon D, McDonald TO, Fareed J, Verrier ED: A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine. J Heart Lung Transplant 12:634–643, 1993 | PubMed | ISI | ChemPort |

Extra navigation

.
ADVERTISEMENT